Simplifying dose regimens - new clarity in patenting procedures
This article was originally published in Scrip
Executive Summary
Recent legislative changes and court rulings have resulted in a simpler and more coherent approach to the patenting of new dosage regimens in Europe. Mark Chacksfield looks at the history of the European position and considers what implications these changes will have for industry.